Latvia vs Sur: Polio vaccine: inactivated second or third-dose polio vaccine (IPVc)
Latvia
99.0%
in 2025
Sur
76.0%
in 2025
Latvia rank
1st
Sur rank
1st
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) over time
- Latvia
- Sur
How they compare
Latvia currently reports 99.0% against 76.0% in Sur, a difference of 23.0%.
That makes Latvia's figure about 1.3 times Sur's.
Across all 5 years both countries report, Latvia has been ahead every year.
Latvia ranks 1st and Sur ranks 1st of 194 countries.
Latvia has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher polio vaccine: inactivated second or third-dose polio vaccine (ipvc), Latvia or Sur?
- Latvia, at 99.0% against 76.0% in Sur as of 2025.
- What is the difference in polio vaccine: inactivated second or third-dose polio vaccine (ipvc) between Latvia and Sur?
- 23.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Sur?
- 5 years are reported by both, from 2021 to 2025.
- How do Latvia and Sur rank globally for polio vaccine: inactivated second or third-dose polio vaccine (ipvc)?
- Latvia ranks 1st and Sur ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.